Syed V A, Ansari J A, Karki P, Regmi M, Khanal B
Department Of Internal Medicine BP Koirala Institute Of Health Sciences, Dharan, Nepal.
Kathmandu Univ Med J (KUMJ). 2007 Jan-Mar;5(1):48-59.
Spontaneous bacterial peritonitis (SBP) is one of the potentially lethal complications of cirrhosis and is defined as infected ascites in the absence of any recognizable secondary cause of infection. Objective was to study the occurrence of SBP, clinical and laboratory characteristics and the response to antibiotics.
We had prospectively evaluated 81 cirrhotic patients with ascites during one-year period. All SBP patients were treated with cefotaxime, 2gm IV, every 12h for 5days.
Of these 81 patients, 24.67% of patients (n=20) had SBP and its variants (classical SBP n= 4, CNNA n=13 and bacterascites n=3). There were thirteen males and 7 females in the study.85% of the cases had Child;s class C cirrhosis. UGI bleeding and abdominal pain were the most common presenting symptoms of SBP. Culture positives were 35% (n=7). The most frequent organisms were Escherichia coli (n=3) and Streptococcus pneumoniae (n=2). 94% of the patients responded to therapy after 48 hours of treatment. Total resolution after 5 days of therapy was 73% and in-hospital mortality was 15% (n=3).
SBP, if diagnosed early can be treated with very good success rate up to 73%. Appropriate treatment of SBP with cefotaxime can help in reducing mortality and morbidity in patients with chronic liver disease.
自发性细菌性腹膜炎(SBP)是肝硬化潜在的致命并发症之一,定义为在无任何可识别的继发感染原因情况下的感染性腹水。目的是研究SBP的发生率、临床和实验室特征以及对抗生素的反应。
我们前瞻性地评估了81例肝硬化腹水患者,为期一年。所有SBP患者均接受头孢噻肟治疗,静脉注射2克,每12小时一次,共5天。
在这81例患者中,24.67%(n = 20)的患者患有SBP及其变体(经典SBP,n = 4;中性粒细胞减少性腹水,n = 13;细菌性腹水,n = 3)。研究中有13名男性和7名女性。85%的病例为Child C级肝硬化。上消化道出血和腹痛是SBP最常见的症状。培养阳性率为35%(n = 7)。最常见的病原体是大肠杆菌(n = 3)和肺炎链球菌(n = 2)。94%的患者在治疗48小时后对治疗有反应。治疗5天后完全缓解率为73%,住院死亡率为15%(n = 3)。
SBP如果早期诊断,治疗成功率可达73%。用头孢噻肟适当治疗SBP有助于降低慢性肝病患者的死亡率和发病率。